J.P. Morgan recently released their mid-year stock market predictions, giving an expected outlook for the rest of 2025. In general, expectations are tempered for growth, with Morgan predicting a ...

Visa's stock price predictions rely on several factors, including analyst forecasts, historical performance and the company’s financial indicators. Analysts determine likely price movements by ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Netflix Inc. (NASDAQ: NFLX) has a lot to celebrate in ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Shares of Nvidia Corp. (NASDAQ: NVDA) are up 18.1% over ...

ASML has what it takes to more than triple over the next decade. The technological powerhouse serves a critical role in the AI value chain. ASML is worthy of a foundational role in a diversified AI ...

Analysts are saying that Boeing could hit $237.92 by 2030. Bullish on BA? Invest in Boeing on SoFi with no commissions. If it’s your first time signing up for SoFi, you’ll receive up to $1,000 in ...

What if the programming language you rely on most is on the brink of a transformation? For millions of developers worldwide, Python is not just a tool, it’s a cornerstone of their craft, powering ...

Opendoor Technologies (NASDAQ: OPEN) was left for dead. Then, it became a meme stock. The real estate platform is up over 500% this year and 20x off the lows set in June, recently surpassing $10 a ...

Amazon has the potential to be a top growth stock in the market. But that's not the case. Amazon is also heavily involved in the AI arms race and has another exciting division that's driving ...

Opendoor stock is soaring because of a new CEO and board member changes. The company has a long way to go if it wants to improve its business model and generate a profit. After soaring 20x in a year, ...

Viking Therapeutics' shares tanked recently after its oral drug, VK2735, spooked investors with a high discontinuation rate. However, it achieved weight loss results similar to Eli Lilly's drug.